Science & Health
Beyond Ozempic: New Triple-Action Jab Shows Record Weight Loss in Diabetes Trial
A new, once-weekly injection called retatrutide has shown record-breaking results in clinical trials, helping diabetes patients lose 15% of body weight.
By Business Desk · 2 hours ago